TAPSE 1.34 cm Indicates Severely Reduced Right Ventricular Function
A TAPSE of 1.34 cm (13.4 mm) is significantly abnormal and indicates severe right ventricular (RV) systolic dysfunction, falling well below the established threshold of 16 mm for normal RV function. This measurement carries important prognostic implications and warrants comprehensive evaluation for underlying causes and associated cardiac abnormalities.
Clinical Significance
- TAPSE <16 mm defines RV systolic dysfunction according to multiple international guidelines 1, 2
- Your value of 13.4 mm is approximately 16% below the lower limit of normal, indicating substantial impairment of RV longitudinal function 1
- This degree of reduction is associated with increased mortality risk across multiple cardiac conditions 3, 4
Prognostic Implications
Mortality and Morbidity:
- In pulmonary arterial hypertension, TAPSE <18 mm confers a 5.7-fold increased risk of death compared to preserved values 3
- For every 1-mm decrease in TAPSE, mortality risk increases by approximately 17% 3
- In systemic sclerosis-associated pulmonary hypertension, TAPSE ≤17 mm is associated with a nearly 4-fold increased risk of death 4
- In acute pulmonary embolism requiring embolectomy, TAPSE <18 mm is an independent predictor of intraoperative cardiopulmonary resuscitation and death 5
Hemodynamic Correlates:
- TAPSE <18 mm is associated with significantly impaired cardiac index (1.9 vs 2.7 L/min/m²), greater RV afterload, and more severe right heart remodeling 3, 4
Essential Complementary Assessment
When TAPSE is reduced, comprehensive evaluation must include 6:
- RV dimensions and function: Mid-RV dimension, RV end-diastolic area (normal ≤28 cm²), RV end-systolic area (normal ≤16 cm²), and RV fractional area change (normal >32%) 6
- Right atrial volume: Normal maximal 2D RA volume ≤33 mL/m² 6
- Inferior vena cava: Diameter (normal <2.1 cm) and respiratory variation to assess right atrial pressure 6
- Systolic pulmonary artery pressure: To evaluate for pulmonary hypertension 6
- Tricuspid regurgitation severity: As severe TR can affect TAPSE accuracy 6
Important Caveats About TAPSE Interpretation
Load Dependency:
- TAPSE is load-dependent and may not reflect true RV myocardial function in severe tricuspid regurgitation or immediately post-cardiac surgery 6
- In patients with severe TR, TAPSE may be less accurate for assessing true RV contractility 6
- TAPSE correlates with RV preload (end-diastolic volume) in addition to ejection fraction, particularly in dilated ventricles 7
RV-PA Coupling:
- The TAPSE/systolic PAP ratio provides additional prognostic information beyond TAPSE alone 8, 9, 10
- A TAPSE/sPAP ratio <0.55 mm/mmHg identifies particularly high-risk patients and is independently associated with adverse cardiovascular events 9
- In acute coronary syndrome, TAPSE/sPAP <0.55 shows a 19-fold increased odds of in-hospital major adverse cardiovascular events 9
Recommended Clinical Actions
Immediate evaluation should focus on:
Identifying the underlying etiology of RV dysfunction 11, 12:
- Left-sided heart disease (most common cause)
- Pulmonary hypertension (primary or secondary)
- Chronic thromboembolic disease
- RV myocardial infarction
- Cardiomyopathy affecting the RV
- Significant tricuspid regurgitation
Assessing for signs of right heart failure 11:
- Elevated jugular venous pressure
- Peripheral edema and ascites
- Hepatic congestion
- Reduced cardiac output symptoms
Considering advanced imaging if echocardiography is suboptimal 11:
- Cardiac MRI for accurate RV volumes and ejection fraction
- Real-time 3D echocardiography
- RV strain imaging for less load-dependent assessment 6
Right heart catheterization may be indicated to:
- Confirm pulmonary hypertension if RVSP >45 mmHg on echo 13
- Assess hemodynamics before major interventions
- Guide therapeutic decisions